Hirtle Callaghan & Co’s Unilever UL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-28,772
Closed -$1.63M 104
2022
Q4
$1.63M Buy
28,772
+9,519
+49% +$509K 0.1% 57
2022
Q3
$950K Buy
19,253
+11,505
+148% +$601K 0.07% 71
2022
Q2
$399K Buy
+7,748
New +$395K 0.02% 92
2022
Q1
Sell
-3,944
Closed -$239K 132
2021
Q4
$239K Buy
+3,944
New +$234K 0.01% 86
2015
Q1
Sell
-165
Closed -$8K 344
2014
Q4
$8K Hold
165
﹤0.01% 447
2014
Q3
$8K Buy
+165
New +$8.15K ﹤0.01% 478
2014
Q2
Sell
-165
Closed -$8K 670
2014
Q1
$8K Hold
165
﹤0.01% 502
2013
Q4
$8K Hold
165
﹤0.01% 480
2013
Q3
$7K Buy
+165
New +$7.49K ﹤0.01% 500

Other funds holding UL

Hirtle Callaghan & Co's UL Position: Q1 2023 in Review

Hirtle Callaghan & Co sold out of Unilever (UL) in Q1 2023, closing a stake of 28,772 shares — an estimated $1.63M sold.

Hirtle Callaghan & Co first reported a position in UL in Q3 2013 and held it in 9 quarters. The position peaked at $1.63M in Q4 2022. 1,104 funds tracked by Wall St. Rank hold UL as of Q1 2023.

  • Hirtle Callaghan & Co reported no remaining Unilever position as of Q1 2023 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 28,772 Unilever shares in Q1 2023, an estimated $1.63M.
  • Hirtle Callaghan & Co first reported a position in Unilever in Q3 2013 and held it in 9 quarters.
  • Hirtle Callaghan & Co's Unilever position peaked at $1.63M in Q4 2022.
  • 1,104 funds tracked by Wall St. Rank held Unilever as of Q1 2023.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2023, filed 11 May 2023.